Highest level of regulatory compliance
Consumer Product Testing Company, a cGMP testing laboratory serving the pharmaceutical, medical device, speciality chemicals and personal care industries for over 36 years announces the successful conclusion of an FDA intensive, five-day general GMP inspection.
The audit also included pre-approval inspections (PAIs) for two client-submitted Abbreviated New Drug Applications (ANDAs)."
We are pleased to announce that no FDA Form 483 non-conformance observations were issued at the conclusion of this inspection.
This is Consumer Product Testing Company's second consecutive GMP inspection without any Form 483 non-conformance observations. We are extremely proud of this record of achievement and will continue to provide the highest level of service at the highest level of regulatory compliance to each of our valued clients.